Loading...

Bayer AG

BAYRY•PNK
Healthcare
Drug Manufacturers - General
$7.96
$0.06(0.79%)

Bayer AG (BAYRY) Stock Overview

Explore Bayer AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.3/100

Key Financials

Market Cap31.3B
P/E Ratio-8.31
EPS (TTM)$-0.96
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$7.60
1 Month$6.91
3 Months$6.12
1 Year Target$3.53

BAYRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bayer AG (BAYRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.47, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.31 and a market capitalization of 31.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;